<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07-PONE-RA-00993R2</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0000651</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Genetics and Genomics/Animal Genetics</subject><subject>Genetics and Genomics/Complex Traits</subject><subject>Genetics and Genomics/Disease Models</subject><subject>Genetics and Genomics/Gene Discovery</subject><subject>Genetics and Genomics/Genetics of Disease</subject></subj-group></article-categories><title-group><article-title>Large-Scale In Silico Mapping of Complex Quantitative Traits in Inbred Mice</article-title><alt-title alt-title-type="running-head">Mapping of Complex Traits</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Pengyuan</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Vikis</surname><given-names>Haris</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Yan</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Daolong</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>You</surname><given-names>Ming</given-names></name><xref rid="aff1" ref-type="aff"/><xref ref-type="corresp" rid="n101"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Surgery and the Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Gwinn</surname><given-names>Katrina</given-names></name><role>Academic Editor</role><xref rid="edit1" ref-type="aff"/></contrib></contrib-group><aff id="edit1">DER Neurogenetics, National Institute of Neurological Disorders and Stroke, United States of America</aff><author-notes><corresp id="n101">&#x0002a; To whom correspondence should be addressed. E-mail: <email>youm@wudosis.wustl.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: MY PL. Performed the experiments: PL HV. Analyzed the data: PL DW YL. Wrote the paper: PL. Other: Revise the manuscript HV.</p></fn></author-notes><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>25</day><month>7</month><year>2007</year></pub-date><volume>2</volume><issue>7</issue><elocation-id>e651</elocation-id><history><date date-type="received"><day>28</day><month>3</month><year>2007</year></date><date date-type="accepted"><day>21</day><month>6</month><year>2007</year></date></history><copyright-statement>Liu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2007</copyright-year><abstract><p>Understanding the genetic basis of common disease and disease-related quantitative traits will aid in the development of diagnostics and therapeutics. The processs of gene discovery can be sped up by rapid and effective integration of well-defined mouse genome and phenome data resources. We describe here an <italic>in silico</italic> gene-discovery strategy through genome-wide association (GWA) scans in inbred mice with a wide range of genetic variation. We identified 937 quantitative trait loci (QTLs) from a survey of 173 mouse phenotypes, which include models of human disease (atherosclerosis, cardiovascular disease, cancer and obesity) as well as behavioral, hematological, immunological, metabolic, and neurological traits. 67&#x00025; of QTLs were refined into genomic regions &#x0003c;0.5 Mb with &#x0223c;40-fold increase in mapping precision as compared with classical linkage analysis. This makes for more efficient identification of the genes that underlie disease. We have identified two QTL genes, <italic>Adam12</italic> and <italic>Cdh2</italic>, as causal genetic variants for atherogenic diet-induced obesity. Our findings demonstrate that GWA analysis in mice has the potential to resolve multiple tightly linked QTLs and achieve single-gene resolution. These high-resolution QTL data can serve as a primary resource for positional cloning and gene identification in the research community.</p></abstract><counts><page-count count="14"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Humans and mice last shared a common ancestor 75 million years ago. Of mouse genes, 99&#x00025; have homologues in humans and 96&#x00025; are in the same syntenic location. Regions of the genome that are highly conserved between the two species align well with functionality <xref ref-type="bibr" rid="pone.0000651-Waterston1">&#x0005b;1&#x0005d;</xref>. The mouse has been a powerful force in elucidating the genetic basis of human physiology and pathophysiology <xref ref-type="bibr" rid="pone.0000651-Peters1">&#x0005b;2&#x0005d;</xref>. Many genetic alterations identified in mouse models have a common genetic equivalent (or ortholog) in humans. In the past decades, quantitative trait locus (QTL) mapping has identified hundreds of chromosomal regions containing genes affecting cancer, diabetes, hypertension, obesity and other disease-related phenotypes in mice. Most of these complex traits show clear genetic components, yet the underlying genes remain largely elusive.</p><p>QTL analysis using mouse models can potentially identify genes that are important for human diseases, which are often difficult to identify in human populations, due to the complexity of human genetic data. However, a major obstacle of identifying QTL genes is the difficulty of resolving these chromosomal regions (10&#x0223c;20 cM) into sufficiently small intervals to make positional cloning possible. Recent advances in genomic sequence analysis and SNP discovery have provided researchers with the necessary resources to explore a wide range of genetic variation in laboratory inbred mice <xref ref-type="bibr" rid="pone.0000651-Wade1">&#x0005b;3&#x0005d;</xref>. The use of dense SNP maps in laboratory inbred mice has proven successful in the refinement of previous QTL regions and the identification of new genetic determinants of complex traits <xref ref-type="bibr" rid="pone.0000651-Liu1">&#x0005b;4&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000651-Valdar1">&#x0005b;8&#x0005d;</xref>. Recently, positional cloning of a novel gene underlying a complex trait was done immediately after a genome-wide association (GWA) analysis <xref ref-type="bibr" rid="pone.0000651-Liu1">&#x0005b;4&#x0005d;</xref>.</p><p>A large and diverse set of traits has been systematically organized in the publicly accessible Mouse Phenome Database (MPD) (<ext-link ext-link-type="uri" xlink:href="http://www.jax.org/phenome">www.jax.org/phenome</ext-link>), housed at The Jackson Laboratory (Bar Harbor, Maine, United States). Rapid and effective integration of mouse genome and phenome data resources can dramatically speed up the process of gene discovery (<xref ref-type="fig" rid="pone-0000651-g001"><bold>Figure 1</bold></xref>). Here, we describe an <italic>in silico</italic> gene-discovery strategy through GWA scans to identify high-resolution QTLs in inbred mice. We further demonstrate that GWA analysis in mice has the potential to resolve multiple tightly linked QTLs and achieve single-gene resolution.</p><fig id="pone-0000651-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000651.g001</object-id><label>Figure 1</label><caption><title>Integration of genomics and phenomics approaches in mapping complex traits in mice.</title><p>(A) Pulmonary adenoma susceptibility locus 1 (<italic>Pas1</italic>) was previously mapped to the distal region of chromosome 6 by linkage analysis in A&#x000d7;B and B&#x000d7;A recombinant inbred mice. (B) <italic>In silico</italic> LD mapping <italic>Pas1</italic> using existing mouse SNP and tumor incidence data. (C) Enhanced view of LD mapping between 144.0&#x02013;146.5 Mb. (D) Physical map of the complex multigenic <italic>Pas1</italic> locus. The <italic>Casc1</italic> gene carries a functional polymorphism at codon 60 (N60S) between lung tumor susceptible strains (e.g. A/J, SWR/J, MA/MyJ and 129/J) and resistant strains (e.g. C57BL/6J, DBA/2J, C3H/HeJ and AKR/J). (E) Lung tumorigenesis of <italic>Casc1</italic> knockout mice. Treatment of Casc1<sup>ko/ko</sup> mice with urethane produced more than six times as many tumors per mouse than did treatment of Casc1<sup>wt-B6/wt-B6</sup> mice. The horizontal coordinates were plotted using physical distance (Mb). In panel A, the horizontal line indicates lod&#x0200a;&#x0003d;&#x0200a;3.3, and tumor multiplicity data were used in the linkage analysis. In panel B and C, the horizontal lines indicate &#x02013;log(P)&#x0200a;&#x0003d;&#x0200a;6.2, and urethane-induced lung adenoma incidence data were used in the analysis <xref ref-type="bibr" rid="pone.0000651-Liu1">&#x0005b;4&#x0005d;</xref>.</p></caption><graphic xlink:href="pone.0000651.g001"/></fig></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>The mouse haplotype map</title><p>We first evaluated the laboratory inbred mouse haplotype map that was used in the analysis. This haplotype map was generated by a joint effort of The Broad Institute of Harvard and MIT, and the Wellcome Trust Center for Human Genetics (<xref ref-type="supplementary-material" rid="pone.0000651.s001"><bold>Text S1</bold></xref>). In total, 148,062 evenly distributed single-nucleotide polymorphisms (SNPs), which span the mouse genome at an average density of &#x0223c;18 kb per SNP, were genotyped in classical inbred mouse strains (<xref ref-type="supplementary-material" rid="pone.0000651.s004"><bold>Figure S1</bold></xref>). Of these SNPs, 96.2&#x00025; have minor allele frequencies greater than 0.05 and 76.7&#x00025; of the inter-SNP distances are smaller than 20 kb. LD decay over the physical distance was observed where the mean <italic>r<sup>2</sup></italic> fell to &#x0003c;0.5 within 2 kb and to less than 0.23 within 200 kb. To capture large-scale patterns of LD, we also measured the number of proxies, i.e. SNPs, showing a strong correlation with one or more others <xref ref-type="bibr" rid="pone.0000651-Altshuler1">&#x0005b;9&#x0005d;</xref>, with a window size of 500 kb across the genome (<xref ref-type="supplementary-material" rid="pone.0000651.s005"><bold>Figure S2</bold></xref>). Using a stringent threshold of <italic>r<sup>2</sup></italic>&#x0200a;&#x0003d;&#x0200a;1.0 (that is complete LD), the average number of proxies per SNP is 2.5, and one in two SNPs have five or more proxies. Of all the SNPs, 89.5&#x00025; have an <italic>r<sup>2</sup></italic>&#x0200a;&#x0003d;&#x0200a;1.0 with at least one other SNP. Using a looser threshold of <italic>r<sup>2</sup></italic>&#x0003e;0.5, the average number of proxies is increased to 6.5, and two in three SNPs have more than five proxies. Of all the SNPs, 91.3&#x00025; have an <italic>r<sup>2</sup></italic>&#x0003e;0.5 with at least one other SNP. These data indicate that the mouse haplotype map provides substantial coverage of genetic variation in inbred mice and is useful for high-resolution genetic mapping studies.</p></sec><sec id="s2b"><title>Analysis of 173 mouse phenotypes</title><p>We performed a comprehensive survey of 173 complex quantitative traits from the mouse PHENOME projects instituted by the Jackson Laboratory (<ext-link ext-link-type="uri" xlink:href="http://www.jax.org/phenome">www.jax.org/phenome</ext-link>). In most PHENOME projects, each phenotype was measured for about 40 strains from a total of 59 inbred strains of mice with a wide range of genetic variation (<xref ref-type="supplementary-material" rid="pone.0000651.s006"><bold>Figure S3</bold></xref> and <xref ref-type="supplementary-material" rid="pone.0000651.s001"><bold>Text S1</bold></xref>). The strains used for phenotyping varied slightly among different PHENOME projects. Generally, at least 10 males and 10 females from each strain were measured for each trait. These complex traits include models of human disease (such as atherosclerosis, cardiovascular disease, cancer, diabetes, obesity, and osteoporosis) as well as behavioral, biochemical, hematological, immunological, metabolic, neurological, and reproductive traits (<xref ref-type="table" rid="pone-0000651-t001"><bold>Table 1</bold></xref>). Most of these 173 mouse quantitative traits are highly heritable, with a mean heritability of 0.51, and 74&#x00025; of these traits have a heritability larger than 0.40 (<xref ref-type="supplementary-material" rid="pone.0000651.s007"><bold>Figure S4</bold></xref>). In general, cancer, taste and drinking preferences show less genetic control (<italic>h<sup>2</sup></italic>&#x0003c;0.3), while body composition and plasma lipid concentrations show larger genetic control (<italic>h<sup>2</sup></italic>&#x0003e;0.7). Of these mouse traits, 47&#x00025; display significant phenotypic differences between males and females (P&#x0003c;0.05), contributing to 1&#x02013;31&#x00025; of the phenotypic variation in the inbred mouse populations. Notably, obesity-related traits such as body weight and fat mass have larger sex effects and explain more than 20&#x00025; of the phenotypic variation in inbred mice. Nevertheless, sex-specific genetic variations are generally small (less than 6&#x00025;) in the inbred mouse populations.</p><table-wrap id="pone-0000651-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000651.t001</object-id><label>Table 1</label><caption><title>Summary of the analyzed mouse traits and QTLs</title></caption><graphic id="pone-0000651-t001-1" xlink:href="pone.0000651.t001"/><table frame="hsides" rules="groups" alternate-form-of="pone-0000651-t001-1"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Categories</td><td align="left" rowspan="1" colspan="1">Description</td><td align="left" rowspan="1" colspan="1">Traits</td><td align="left" rowspan="1" colspan="1">QTLs</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Blood biochemistry</td><td align="left" rowspan="1" colspan="1">Blood calcium and pH, coagulation factors, glucose, leptin, insulin, peptides and proteins</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">59</td></tr><tr><td align="left" rowspan="1" colspan="1">Body composition</td><td align="left" rowspan="1" colspan="1">Body weight, fat mass and lean mass on normal chow and atherogenic diet</td><td align="left" rowspan="1" colspan="1">24</td><td align="left" rowspan="1" colspan="1">118</td></tr><tr><td align="left" rowspan="1" colspan="1">Cancer</td><td align="left" rowspan="1" colspan="1">Metastatic progression, tumor latency, and tumor burden</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Cholesterol</td><td align="left" rowspan="1" colspan="1">Total cholesterol, HDL cholesterol, nonHDL cholesterol, and hepatic cholesterol</td><td align="left" rowspan="1" colspan="1">20</td><td align="left" rowspan="1" colspan="1">206</td></tr><tr><td align="left" rowspan="1" colspan="1">Drinking preference</td><td align="left" rowspan="1" colspan="1">Drinking preference for ammonium, calcium, potassium, sodium chloride and/or lactate</td><td align="left" rowspan="1" colspan="1">29</td><td align="left" rowspan="1" colspan="1">137</td></tr><tr><td align="left" rowspan="1" colspan="1">Gallbladder and gallstones</td><td align="left" rowspan="1" colspan="1">Gallbladder volume, mucin, liquid crystals, monohydrate crystals, sandy stones, and gallstones</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">23</td></tr><tr><td align="left" rowspan="1" colspan="1">Hematology</td><td align="left" rowspan="1" colspan="1">Complete blood count, red blood cell parameters, and platelets</td><td align="left" rowspan="1" colspan="1">19</td><td align="left" rowspan="1" colspan="1">128</td></tr><tr><td align="left" rowspan="1" colspan="1">Liver pathology</td><td align="left" rowspan="1" colspan="1">Diet-induced liver pathology including liver weight, alanine aminotransferase, bile salts, microvacuoles, macrovacuoles and inflammation</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">22</td></tr><tr><td align="left" rowspan="1" colspan="1">Musculoskeletal</td><td align="left" rowspan="1" colspan="1">Bone mineral content and density</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">59</td></tr><tr><td align="left" rowspan="1" colspan="1">Neurological</td><td align="left" rowspan="1" colspan="1">Acoustic startle response, hearing, and prepulse inhibition</td><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">123</td></tr><tr><td align="left" rowspan="1" colspan="1">Reproduction</td><td align="left" rowspan="1" colspan="1">Reproductive performance such as number of litters per dam and number of mice per litter</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">Triglycerides</td><td align="left" rowspan="1" colspan="1">Triglycerides on normal chew and atherogenic diet</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">56</td></tr><tr><td align="left" rowspan="1" colspan="1">Others</td><td align="left" rowspan="1" colspan="1">Daily average food and water intake</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">0</td></tr></tbody></table></table-wrap></sec><sec id="s2c"><title>Identification of 937 QTLs</title><p>To identify the genetic basis of this large and diverse set of mouse phenotypes, we designed an <italic>in silico</italic> approach for gene identification through GWA scans in inbred mice. In our approach, GWA scans were implemented in an automatic processing pipeline which constitutes data retrieving, outlier detection, data preprocessing, hypothesis testing, permutation testing and QTL identification. The potential problem of population structure in inbred mice was also inspected (<xref ref-type="supplementary-material" rid="pone.0000651.s008"><bold>Figure S5</bold></xref> and <xref ref-type="supplementary-material" rid="pone.0000651.s001"><bold>Text S1</bold></xref>). Totally, we identified 937 QTLs from the survey of 173 complex quantitative traits in inbred mice. These QTLs affect almost all types of mouse phenotypes and are distributed unevenly on all of the mouse chromosomes except chromosome Y (<xref ref-type="fig" rid="pone-0000651-g002"><bold>Figure 2A</bold></xref>, and <xref ref-type="supplementary-material" rid="pone.0000651.s002"><bold>Table S1</bold></xref> and <xref ref-type="supplementary-material" rid="pone.0000651.s003"><bold>S2</bold></xref>). The number of QTLs per trait ranges from 0 to 38, with a mean of 5.4 (<xref ref-type="fig" rid="pone-0000651-g002"><bold>Figure 2B</bold></xref>). The average size of a QTL region is 0.54 Mb and 67&#x00025; of the QTLs were mapped to genomic regions less than 0.5 Mb (<xref ref-type="fig" rid="pone-0000651-g002"><bold>Figure 2C</bold></xref>). This translates to an extraordinary &#x0223c;40-fold increase in mapping precision as compared with clasical linkage analysis. In addition, about 20&#x00025; of the QTLs were located within genomic regions less than 100 kb away from at least one other QTL, implying the prevalence of pleiotropic effects of genetic manipulation in mice.</p><fig id="pone-0000651-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000651.g002</object-id><label>Figure 2</label><caption><title>937 QTLs identified by genome-wide association analysis.</title><p>(A) Distribution of 937 QTLs on the mouse genome. The scatter plots were drawn for &#x02013;log(P) against the peak of QTLs on the chromosomes. Each square represents an identified QTL. (B) The number of QTLs per trait. (C) Proportion of QTL intervals in Mb.</p></caption><graphic xlink:href="pone.0000651.g002"/></fig><p><xref ref-type="supplementary-material" rid="pone.0000651.s009"><bold>Figure S6</bold></xref> shows a general QTL landscape from our GWA scans of several obesity-related phenotypes, including body weight and lean mass on normal chow and high fat, high cholesterol atherogenic diets. The analyses identified a large number of QTLs, most of which contained multiple significant SNPs clustering in the same genomic region. Several QTLs affecting multiple obesity phenotypes were repeatedly mapped to the identical locations on distal chromosome 1 and proximal chromosome 13 in different datasets. Most of these QTLs are broadly concordant with those detected previously by linkage analyses which, however, normally encompassed 10&#x02013;20 cM (about 20 to 40 Mb on the mouse genome) <xref ref-type="bibr" rid="pone.0000651-Rankinen1">&#x0005b;10&#x0005d;</xref>. In some scenarios, several separated QTLs from the GWA scans were mapped to a single linkage-defined QTL region. This lack of precision is mainly due to limited recombinants in these linkage mapping populations. Our GWA scans also found several novel QTLs that do not overlap with previous linkage analysis regions (<xref ref-type="supplementary-material" rid="pone.0000651.s009"><bold>Figure S6</bold></xref>). For example, we fine mapped a novel obesity QTL to a region of approximately 700 Kb (33.98&#x02013;34.71 Mb) on proximal chromosome 9, which covers two candidates: Kirrel3 and A130066N16Rik; and mapped a novel QTL to a region of approximately 100 Kb (56.28&#x02013;56.37 Mb) on distal chromosome 19, which covers Habp2 and Nrap. These novel QTLs identified in the GWA are not unexpected since association mapping detects allelic associations at the level of the population, which is normally comprised of 30&#x02013;40 genetically diverse inbred mouse strains, rather than allelic difference between two specific parental strains in linkage mapping. Furthermore, all the obesity QTL regions detected by the GWA analyses using natural inbred mouse population samples are much smaller (less than 0.6 Mb on average with the present SNP density of 18 kb per SNP) as compared with linkage analyses. This makes positional cloning feasible immediately after GWA scans without the need for further time-comsuming fine mapping with congenic strains.</p></sec><sec id="s2d"><title>Dissection of multiple tightly linked QTLs</title><p>GWA scans help resolve multiple, tightly linked QTLs. We again used obesity QTLs to demonstrate this potential. So far, at least 12 obesity QTLs have been mapped to distal mouse chromosome 1, and most of them overlap with each other and may be linked to the same gene (<xref ref-type="fig" rid="pone-0000651-g003"><bold>Figure 3A</bold></xref>). Among these, Bwtq1 was originally identified in a cross between DBA/2J and C57BL/6J <xref ref-type="bibr" rid="pone.0000651-Morris1">&#x0005b;11&#x0005d;</xref> and later refined to an 8-cM region (&#x0223c;33 Mb) between D1Mit30 and D1Mit57 <xref ref-type="bibr" rid="pone.0000651-Christians1">&#x0005b;12&#x0005d;</xref>. This QTL has a general effect on body size, affecting the length of the tail and most bones studied, as well as having a weaker effect on mass. Using congenic strains, Bwtq1 was narrowed down to a 1.4-cM region (&#x0223c;4 Mb), approximately the region from D1Mit451 to D1Mit219 <xref ref-type="bibr" rid="pone.0000651-Christians2">&#x0005b;13&#x0005d;</xref>. The location of Bwtq1 was further refined to 0.91 Mb between D1Icp7 and D1Icp10 using interval-specific subcongenic strains, which led to the identification of a strong candidate, <italic>Pappa2</italic>, encoding an enzyme that cleaves an insulin-like growth factor binding protein (<xref ref-type="fig" rid="pone-0000651-g003"><bold>Figure 3B</bold></xref>) <xref ref-type="bibr" rid="pone.0000651-Christians3">&#x0005b;14&#x0005d;</xref>. However, our GWA scans identified two closely linked QTLs within 5 Mb of each other on distal chromosome 1. One is associated with several different obesity phenotypes in three independent datasets and is located within 153.5&#x02013;155.5 Mb (&#x02013;log(P)&#x0200a;&#x0003d;&#x0200a;8.2&#x02013;11.4) and the other reproduced the refined Bwtq1 QTL, showing significant effects on body weight and bone mineral content (&#x02013;log(P)&#x0200a;&#x0003d;&#x0200a;7.2). These results illustrate the robustness and reproducibility of GWA scans for complex quantitative traits in inbred mice.</p><fig id="pone-0000651-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000651.g003</object-id><label>Figure 3</label><caption><title>Dissection of multiple tightly linked QTLs.</title><p>(A) Obesity QTLs were mapped to distal mouse hromosome 1 by linkage analysis from cross-breeding experiments <xref ref-type="bibr" rid="pone.0000651-Rankinen1">&#x0005b;10&#x0005d;</xref>. Approximately one LOD interval was plotted against its LOD at the QTL peak. The diamonds indicate QTL peaks. Each peak lists the names of the defined QTL. (B) LD mapping of several obesity-related phenotypes in distal mouse chromosome 1. LD mapping identified two closely linked QTLs on distal chromosome 1. One is located within 153.5&#x02013;155.5 Mb; another reproduced the previously refined QTL, Bwtq1. The analyzed phenotypes are body weight at the start of testing (8 weeks) (Tordoff3_bw_start), calculated weight of lean tissue (14 weeks) (Tordoff3_lean_wt), body weight after 8 weeks on an atherogenic diet (Naggert1_bw_fat8), total tissue mass after 8 weeks on an atherogenic diet (Naggert1_tissuemass_fat8), weight of lean portion of tissue mass after 8 weeks on an atherogenic diet (Naggert1_leanwt_fat8), bone mineral content after 8 weeks on an atherogenic diet (Naggert1_BMC_fat8), initial body weight (7&#x02013;9 weeks) (Paigen1_initbw), and final body weight after 8 weeks on an atherogenic diet (Paigen1_finalbw).</p></caption><graphic xlink:href="pone.0000651.g003"/></fig></sec><sec id="s2e"><title>Murine knockout and/or transgenic models</title><p>The refined region of previous QTLs was reduced, on average, to 0.54 Mb, which covers on average 6 genes on the mouse genome. Characterization of such a small number of genes in each of these QTLs can greatly accelerate the discovery of genes underlying complex traits. We further performed a detailed survey of QTLs for all obesity-related phenotypes such as body weight, fat mass, lean mass and leptin levels. Of the QTLs detected in the present study, we identified 10 candidate genes within these QTLs that, when mutated or overexpressed as transgenes in the mouse, result in phenotypes affecting body weight and adiposity. These genes include Gpr39 (G protein-coupled receptor 39), Crhr2 (corticotropin releasing hormone receptor 2), Cdkn1b (cyclin-dependent kinase inhibitor 1B), Adam12 (ADAM metallopeptidase domain 12), Rasgrf1 (RAS protein-specific guanine nucleotide-releasing factor 1), Chrm3 (cholinergic receptor, muscarinic 3), Mapk8 (mitogen activated protein kinase 8), Wnt10b (wingless related MMTV integration site 10b), Dusp1 (dual specificity phosphatase 1) and Cdh2 (cadherin 2) (<xref ref-type="table" rid="pone-0000651-t002"><bold>Table 2</bold></xref>). For example, an obesity QTL on the proximal chromosome 13 has been replicated in at least four linkage studies <xref ref-type="bibr" rid="pone.0000651-Brockmann1">&#x0005b;15&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000651-Vaughn1">&#x0005b;18&#x0005d;</xref>, and has not yet been narrowed down. Our GWA scans identified a refined QTL (8.0&#x02013;10.0 Mb) covering the gene Chrm3 to be associated with four obesity phenotypes in three independent datasets (-log(P)&#x0200a;&#x0003d;&#x0200a;6.7&#x02013;8.6) (<xref ref-type="fig" rid="pone-0000651-g004"><bold>Figure 4A</bold></xref>). Chrm3 is a member of the muscarinic acetylcholine receptors that play critical roles in regulating the activity of many important functions of the central and peripheral nervous system <xref ref-type="bibr" rid="pone.0000651-Bymaster1">&#x0005b;19&#x0005d;</xref>. Chrm3 knockout mice had a significant reduction in food intake, body weight (25&#x00025;), and peripheral fat deposits. The lack of Chrm3 also led to pronounced reductions (&#x0223c;5&#x02013;10-fold) in serum leptin and insulin levels <xref ref-type="bibr" rid="pone.0000651-Yamada1">&#x0005b;20&#x0005d;</xref>.</p><fig id="pone-0000651-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000651.g004</object-id><label>Figure 4</label><caption><title>Fine mapping of Chrm3 and Apoa2.</title><p>(A) Chrm3 is associated with initial body weight (7&#x02013;9 weeks), day 0 of an atherogenic diet (Paigen1_initbw), final body weight after 8 weeks on atherogenic diet (Paigen1_finalbw), calculated weight of lean tissue (14 weeks) (Tordoff3_lean_wt), and body weight after 8 weeks on an atherogenic diet (Naggert1_bw_fat8) in the GWA scan. The Chrm3 region has been replicated in at least four obesity linkage studies. (B) Apoa2 is associated with percent of total plasma cholesterol in the HDL fraction after 8 weeks on an atherogenic diet (Paigen1_ pctHDL-TCH) in the GWA scan. The Apoa2 region has been repeatedly detected by linkage analyses in 12 different genetic crosses. Relevant phenotypes for these two genes were already observed in murine knockout models. The horizontal gray lines indicate genome-wide empirical thresholds.</p></caption><graphic xlink:href="pone.0000651.g004"/></fig><table-wrap id="pone-0000651-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000651.t002</object-id><label>Table 2</label><caption><title>Candidate genes for obesity validated in murine knockout and/or transgenic models</title></caption><graphic id="pone-0000651-t002-2" xlink:href="pone.0000651.t002"/><table frame="hsides" rules="groups" alternate-form-of="pone-0000651-t002-2"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Gene<xref ref-type="table-fn" rid="nt101">a</xref></td><td align="left" rowspan="1" colspan="1">Chr</td><td align="left" rowspan="1" colspan="1">QTL peak<xref ref-type="table-fn" rid="nt102">b</xref></td><td align="left" rowspan="1" colspan="1">Analyzed trait<xref ref-type="table-fn" rid="nt103">c</xref></td><td align="left" rowspan="1" colspan="1"><italic>-log(P)</italic></td><td align="left" rowspan="1" colspan="1">Phenotypes in KO or TG mice<xref ref-type="table-fn" rid="nt104">d</xref></td><td align="left" rowspan="1" colspan="1">Ref.</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Gpr39</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">127,875,052</td><td align="left" rowspan="1" colspan="1">Percent of tissue mass that is fat, after 8 wks on atherogenic diet (Naggert1)</td><td align="left" rowspan="1" colspan="1"><italic>6.1</italic></td><td align="left" rowspan="1" colspan="1">Increased body weight and body fat composition (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Moechars1">&#x0005b;27&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Crhr2</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">55,858,855</td><td align="left" rowspan="1" colspan="1">Leptin, after 18 wks on atherogenic diet (Naggert1)</td><td align="left" rowspan="1" colspan="1"><italic>6.3</italic></td><td align="left" rowspan="1" colspan="1">Lower body fat and plasma lipids, increased insulin sensitivity, and lower feed efficiency on high-fat diet (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Bale1">&#x0005b;47&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Cdkn1b</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">134,947,686</td><td align="left" rowspan="1" colspan="1">Percent fat (Tordoff3)</td><td align="left" rowspan="1" colspan="1">7.4</td><td align="left" rowspan="1" colspan="1">Increased body fat percentage, annd increased adiposity (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Naaz1">&#x0005b;48&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">134,947,686</td><td align="left" rowspan="1" colspan="1">Percent lean (Tordoff3)</td><td align="left" rowspan="1" colspan="1">7.3</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Adam12</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">133,991,842</td><td align="left" rowspan="1" colspan="1">Percent of tissue mass that is fat, after 8 wks on atherogenic diet (Naggert1)</td><td align="left" rowspan="1" colspan="1"><italic>6.5</italic></td><td align="left" rowspan="1" colspan="1">Moderate resistance to diet-induced obesity due to an impairment in the increase of the number of adipocytes in high-fat-fed mice (TG)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Masaki1">&#x0005b;24&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Rasgrf1</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">89,769,476</td><td align="left" rowspan="1" colspan="1">Percent fat (Tordoff3)</td><td align="left" rowspan="1" colspan="1"><italic>7.5</italic></td><td align="left" rowspan="1" colspan="1">Reduced body weight, adiposity and &#x0223c;20&#x00025; decreased gonadal fat percentage (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-FontdeMora1">&#x0005b;49&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Chrm3</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">8,305,114</td><td align="left" rowspan="1" colspan="1">Final body weight after 8 wks on atherogenic diet (Paigen1)</td><td align="left" rowspan="1" colspan="1">7.9</td><td align="left" rowspan="1" colspan="1">Reduced adiposity and decreased &#x0223c;25&#x00025; body weight (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Yamada1">&#x0005b;20&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">10,048,424</td><td align="left" rowspan="1" colspan="1">Calculated weight of lean tissue (Tordoff3)</td><td align="left" rowspan="1" colspan="1">8.6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">10,065,064</td><td align="left" rowspan="1" colspan="1">Initial body weight (Paigen1)</td><td align="left" rowspan="1" colspan="1">8.6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">10,065,799</td><td align="left" rowspan="1" colspan="1">Body weight after 8 wks on atherogenic diet (Naggert1)</td><td align="left" rowspan="1" colspan="1">6.7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Mapk8</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1">32,376,554</td><td align="left" rowspan="1" colspan="1">Leptin, after 18 wks on atherogenic diet (Naggert1)</td><td align="left" rowspan="1" colspan="1"><italic>6.3</italic></td><td align="left" rowspan="1" colspan="1">Reduced body weight and increased insulin sensitivity (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Tuncman1">&#x0005b;50&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Wnt10b</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">98,434,034</td><td align="left" rowspan="1" colspan="1">Percent of tissue mass that is fat, after 8 wks on atherogenic diet (Naggert1)</td><td align="left" rowspan="1" colspan="1"><italic>6.1</italic></td><td align="left" rowspan="1" colspan="1">Tesistant to diet-induced obesity and loss of brown adipose tissue (TG)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Longo1">&#x0005b;51&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Dusp1</td><td align="left" rowspan="1" colspan="1">17</td><td align="left" rowspan="1" colspan="1">25,910,596</td><td align="left" rowspan="1" colspan="1">Percent of tissue mass that is fat, after 8 wks on atherogenic diet (Naggert1)</td><td align="left" rowspan="1" colspan="1"><italic>7.4</italic></td><td align="left" rowspan="1" colspan="1">Resistant to diet-induced obesity but succumb to glucose intolerance on a high fat diet (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Wu1">&#x0005b;52&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Cdh2</td><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">16,917,241</td><td align="left" rowspan="1" colspan="1">Liver weight at sacrifice, after 8 wks on atherogenic diet (Paigen1)</td><td align="left" rowspan="1" colspan="1"><italic>8.2</italic></td><td align="left" rowspan="1" colspan="1">Increased adiposity (TG)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Castro1">&#x0005b;25&#x0005d;</xref></td></tr></tbody></table><table-wrap-foot><fn id="nt101"><label>a</label><p>Genes were located within the identified QTLs.</p></fn><fn id="nt102"><label>b</label><p>Physical position (bp) was based on the NCBI mouse genome build 36.1.</p></fn><fn id="nt103"><label>c</label><p>Traits were analyzed in the GWA scans; name of the PHENOME projects was indicated in the parentheses.</p></fn><fn id="nt104"><label>d</label><p>Relevant phenotypes were observed in murine knockout (KO) and/or transgenic (TG) models.</p></fn></table-wrap-foot></table-wrap><p>Similarly, we performed a survey of QTLs for plasma lipid levels which are correlated with the risk of atherosclerotic coronary heart disease <xref ref-type="bibr" rid="pone.0000651-Brewer1">&#x0005b;21&#x0005d;</xref>. We identified 11 candidate genes in the refined regions of QTLs affecting levels of high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, and triglycerides. These genes are Gpr39 (G protein-coupled receptor 39), Apoa2 (apolipoprotein A-II), Cd36 (CD36 antigen), Cckar (cholecystokinin A receptor), Npy (neuropeptide Y), Pparg (peroxisome proliferator activated receptor gamma), Ccr2 (chemokine (C-C motif) receptor 2), Acaca (acetyl-Coenzyme A carboxylase alpha), Apob (apolipoprotein B), Soat2 (sterol O-acyltransferase 2) and Lipg (endothelial lipase) (<xref ref-type="table" rid="pone-0000651-t003"><bold>Table 3</bold></xref>). All of these genes were observed to have strong involvement in plasma lipid phenotypes in murine knockout and/or transgenic models. Notably, we identified a QTL containing Apoa2 on chromosome 1 located at 173.0&#x02013;173.9 Mb, which affects the percent of total plasma cholesterol in the HDL fraction after 8 weeks on an atherogenic diet (-log(P)&#x0200a;&#x0003d;&#x0200a;7.9) (<xref ref-type="fig" rid="pone-0000651-g004"><bold>Figure 4B</bold></xref>). Apoa2 is located within a strong HDL QTL, hdlq5, which has been repeatedly detected on distal chromosome 1 by linkage analyses in 12 different genetic crosses <xref ref-type="bibr" rid="pone.0000651-Rollins1">&#x0005b;22&#x0005d;</xref>. Homozygous Apoa2 knockout mice had 67&#x00025; and 52&#x00025; reductions in HDL cholesterol levels in the fasted and fed states, respectively, and HDL particle size was also reduced <xref ref-type="bibr" rid="pone.0000651-Weng1">&#x0005b;23&#x0005d;</xref>.</p><table-wrap id="pone-0000651-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000651.t003</object-id><label>Table 3</label><caption><title>Candidate genes for plasma lipid levels validated in murine knockout and/or transgenic models</title></caption><graphic id="pone-0000651-t003-3" xlink:href="pone.0000651.t003"/><table frame="hsides" rules="groups" alternate-form-of="pone-0000651-t003-3"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Gene<sup>a</sup></td><td align="left" rowspan="1" colspan="1">Chr</td><td align="left" rowspan="1" colspan="1">QTL peak</td><td align="left" rowspan="1" colspan="1">Analyzed trait</td><td align="left" rowspan="1" colspan="1"><italic>-log(P)</italic></td><td align="left" rowspan="1" colspan="1">Phenotypes in KO or TG mice</td><td align="left" rowspan="1" colspan="1">Ref.</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Gpr39</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">127,218,849</td><td align="left" rowspan="1" colspan="1">Total cholesterol, after 17 wks on atherogenic diet (Paigen2)</td><td align="left" rowspan="1" colspan="1">8.8</td><td align="left" rowspan="1" colspan="1">Increased 11&#x00025; and 42&#x00025; cholesterol levels in males and females, respectively (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Moechars1">&#x0005b;27&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">127,775,854</td><td align="left" rowspan="1" colspan="1">Fold change in total cholesterol after 17 wks on atherogenic diet (Paigen2)</td><td align="left" rowspan="1" colspan="1">6.6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">127,775,854</td><td align="left" rowspan="1" colspan="1">Non-HDL cholesterol, after 17 wks on atherogenic diet (Paigen2)</td><td align="left" rowspan="1" colspan="1">9.9</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Apoa2</td><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">173,030,894</td><td align="left" rowspan="1" colspan="1">Percent of total plasma cholesterol in HDL fraction, after 8 wks on atherogenic diet (Paigen1)</td><td align="left" rowspan="1" colspan="1"><italic>7.9</italic></td><td align="left" rowspan="1" colspan="1">Reduced HDL cholesterol levels and HDL particle size (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Weng1">&#x0005b;23&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Cd36</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">16,119,658</td><td align="left" rowspan="1" colspan="1">Non-HDL cholesterol, after 17 wks on atherogenic diet (Paigen2)</td><td align="left" rowspan="1" colspan="1"><italic>7.1</italic></td><td align="left" rowspan="1" colspan="1">Increased plasma free fatty acid and triglyceride levels and decreased glucose levels (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Goudriaan1">&#x0005b;53&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Cckar</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">53,817,933</td><td align="left" rowspan="1" colspan="1">Triglycerides (Paigen4)</td><td align="left" rowspan="1" colspan="1">7.5</td><td align="left" rowspan="1" colspan="1">Increased cholesterol gallstone formation (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Miyasaka1">&#x0005b;54&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">54,607,854</td><td align="left" rowspan="1" colspan="1">Triglycerides (Paigen2)</td><td align="left" rowspan="1" colspan="1">7.7</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Npy</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">50,629,612</td><td align="left" rowspan="1" colspan="1">Triglycerides (Paigen4)</td><td align="left" rowspan="1" colspan="1"><italic>7.7</italic></td><td align="left" rowspan="1" colspan="1">Decreased 18&#x00025; and 27&#x00025; Triglycerides in fasted and refed mice (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Patel1">&#x0005b;55&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Pparg</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">116,114,107</td><td align="left" rowspan="1" colspan="1">Hepatic cholesterol concentration, after 8 wks on atherogenic diet (Paigen1)</td><td align="left" rowspan="1" colspan="1"><italic>6.9</italic></td><td align="left" rowspan="1" colspan="1">Reduced cholesterol efflux and HDL levels (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Akiyama1">&#x0005b;56&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Ccr2</td><td align="left" rowspan="1" colspan="1">9</td><td align="left" rowspan="1" colspan="1">123,799,254</td><td align="left" rowspan="1" colspan="1">Non-HDL cholesterol, after 17 wks on atherogenic diet (Paigen2)</td><td align="left" rowspan="1" colspan="1"><italic>6.8</italic></td><td align="left" rowspan="1" colspan="1">Decreased 20&#x00025; and 17&#x00025; total cholesterol levels in low- and high-fat diet, respectively (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Weisberg1">&#x0005b;57&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Acaca</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1">85,561,821</td><td align="left" rowspan="1" colspan="1">Non-HDL cholesterol, after 17 wks on atherogenic diet (Paigen2)</td><td align="left" rowspan="1" colspan="1"><italic>6.8</italic></td><td align="left" rowspan="1" colspan="1">Decrease in the de novo fatty acid synthesis and triglyceride accumulation in the liver (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Mao1">&#x0005b;58&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Apob</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">7,813,147</td><td align="left" rowspan="1" colspan="1">Hepatic cholesterol concentration, after 8 wks on atherogenic diet (Paigen1)</td><td align="left" rowspan="1" colspan="1"><italic>7.1</italic></td><td align="left" rowspan="1" colspan="1">Decreased &#x0223c;37&#x02013;39&#x00025; total cholesterol, LDL, and HDL levels (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Huang1">&#x0005b;59&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Soat2</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">101,357,816</td><td align="left" rowspan="1" colspan="1">Hepatic cholesterol concentration, after 8 wks on atherogenic diet (Paigen1)</td><td align="left" rowspan="1" colspan="1"><italic>6.5</italic></td><td align="left" rowspan="1" colspan="1">Resistance to diet-induced hypercholesterolemia and gallstone formation (KO)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Buhman1">&#x0005b;60&#x0005d;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Lipg</td><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">74,969,883</td><td align="left" rowspan="1" colspan="1">Triglycerides (Paigen4)</td><td align="left" rowspan="1" colspan="1"><italic>7.2</italic></td><td align="left" rowspan="1" colspan="1">Fasting plasma HDL cholesterol was increased by 57&#x00025; in Lipg&#x02013;/&#x02013; and 25&#x00025; in Lipg&#x0002b;/&#x02013; mice and was decreased by 19&#x00025; in Lipg transgenic mice (KO/TG)</td><td align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="pone.0000651-Ishida1">&#x0005b;61&#x0005d;</xref></td></tr></tbody></table></table-wrap></sec><sec id="s2f"><title>Adam12 and Cdh2 mapped with single-gene resolution by GWA scans</title><p>GWA scans have the potential to achieve single-gene resolution, depending on local LD patterns and gene density on the mouse genome. A closer view of the above 10 obesity candidate-gene regions (<xref ref-type="table" rid="pone-0000651-t002"><bold>Table 2</bold></xref>) further identified two QTLs that were mapped with single-gene resolution. One QTL significantly affects the percent of fat mass after 8 weeks on an atherogenic diet (-log(P)&#x0200a;&#x0003d;&#x0200a;6.5) and is located on chromosome 7 spanning less than 100 kb where Adam12 is the only candidate gene (<xref ref-type="fig" rid="pone-0000651-g005"><bold>Figure 5A</bold></xref>). Meltrin alpha (Adam12) is a metalloprotease-disintegrin that belongs to the ADAM (for &#x0201c;a disintegrin and metalloprotease&#x0201d;) family. Compared with wild-type mice, meltrin alpha(-/-) mice displayed moderate resistance to weight gain induced by a high-fat diet, mainly because of an increase in the number of adipocytes <xref ref-type="bibr" rid="pone.0000651-Masaki1">&#x0005b;24&#x0005d;</xref>. Another QTL is significantly associated with mouse liver weight after 8 weeks on an atherogenic diet (-log(P)&#x0200a;&#x0003d;&#x0200a;8.2) and is located on chromosome 18, spanning less than 100 kb, where Cdh2 is the only candidate gene (<xref ref-type="fig" rid="pone-0000651-g005"><bold>Figure 5B</bold></xref>). N-cadherin (Cdh2) is a classical cadherin from the cadherin superfamily. Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis when compared with wild-type littermates <xref ref-type="bibr" rid="pone.0000651-Castro1">&#x0005b;25&#x0005d;</xref>. Since Adam12 and Cdh2 are the only candadiate gene in each of their QTL regions and further supported by the evidence from knockout and/or transgenic mice, we can safely establish these two QTL genes as casual genetic variants for atherogenic diet-induced obesity in natural inbred mouse populations. It should be noted that evidence solely from knockout or transgenic mice is not sufficient to infer causal relationship between a particular gene and disease in natural populations since the gene that was knocked out or overexpressed in mice may be only one of the several genes involved in the same biological pathway leading to the disease, rather than the true gene that is mutated in natural populations. Only when genetic mapping data, especially from high-resolution QTL analyses that identify allelic variants associated with the disease, are incorporated with murine knockout or transgenic models can the casual relationship be firmly established.</p><fig id="pone-0000651-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000651.g005</object-id><label>Figure 5</label><caption><title>Adam12 and Cdh2 were mapped to single-gene resolution.</title><p>(A) Adam12 is associated with the percent of fat mass after 8 weeks on an atherogenic diet (Naggert1_pctfat_fat8). (B) Cdh2 is associated with liver weight after 8 weeks on an atherogenic diet (Paigen1_liverweight). Relevant phenotypes for these two genes were already observed in murine knockout or transgenic models. In each subfigure, the upper panel is the enhanced view of LD mapping in a short region around the LD peak, and the lower panel is the physical map of the associated refined QTL. Genes shown on the upper side of the chromosome (turquoise lines) are transcribed in the&#x02013;orientation (from right to left), and those on the lower side (pink lines) in the&#x0002b;orientation (from left to right). The horizontal gray lines indicate genome-wide empirical thresholds. Physical position was based on the latest NCBI mouse genome build 36.1.</p></caption><graphic xlink:href="pone.0000651.g005"/></fig></sec><sec id="s2g"><title>Gpr39 mapped in a pleiotropic QTL</title><p>Among these 21 candidate genes (<xref ref-type="table" rid="pone-0000651-t002"><bold>Table 2</bold></xref> and <xref ref-type="table" rid="pone-0000651-t003"><bold>3</bold></xref>), Gpr39 has knockout phenotypes on both obesity and plasma lipid levels. Our GWA scans identified a QTL on chromosome 1 affecting percent fat mass on atherogenic diet (-log(P)&#x0200a;&#x0003d;&#x0200a;6.1). This QTL colocalizes with another QTL identified by our GWA scans, which affects total cholesterol and non-HDL cholesterol levels, and fold change in total cholesterol levels after 17 weeks on atherogenic diet (-log(P)&#x0200a;&#x0003d;&#x0200a;6.6&#x02013;9.9) (<xref ref-type="fig" rid="pone-0000651-g006"><bold>Figure 6</bold></xref>). The genomic locations of these two overlapped QTLs are indistinguishable which are very likely controlled by the same gene with pleiotropic effects on obesity and plasma lipid levels. The critical region of this pleiotropic QTL spans about 0.7 Mb (127.2&#x02013;127.9 Mb) and covers six annotated genes based on the latest NCBI mouse genome build 36.1, including Actr3, Slc35f5, Gpr39, LOC667043, Lypd1 and E030049G20Rik. Gpr39 is a member of a family that includes the receptors for ghrelin and motilin <xref ref-type="bibr" rid="pone.0000651-Zhang1">&#x0005b;26&#x0005d;</xref>. Mature body weight and percent fat mass were increased by 38&#x00025; and 5&#x00025;, respectively, in Gpr39 loss-of-function (Gpr39<sup>&#x02212;/&#x02212;</sup>) mice; cholesterol levels were increased by 11&#x00025; and 42&#x00025; in male and female Gpr39<sup>&#x02212;/&#x02212;</sup> mice, respectively <xref ref-type="bibr" rid="pone.0000651-Moechars1">&#x0005b;27&#x0005d;</xref>. This establishes Gpr39 as a candidate for this pleiotropic QTL affecting both obesity and plasma lipid levels, even in light of the fact of recent observations clouding its role <xref ref-type="bibr" rid="pone.0000651-Chartrel1">&#x0005b;28&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000651-Tremblay1">&#x0005b;31&#x0005d;</xref>. Nevertheless, these remarkable phenotypic differences between Gpr39<sup>&#x02212;/&#x02212;</sup> and wild-type mice mentioned above were only observed at old age (about 50 weeks for obesity and 25 weeks for cholesterol) <xref ref-type="bibr" rid="pone.0000651-Moechars1">&#x0005b;27&#x0005d;</xref>, suggesting that deleterious mutations in Gpr39 may increase the risk for late-onset obesity and atherosclerotic coronary heart disease.</p><fig id="pone-0000651-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000651.g006</object-id><label>Figure 6</label><caption><title>Gpr39 was mapped in a pleiotropic QTL.</title><p>Gpr39 is associated with percent of tissue mass that is fat after 8 weeks on atherogenic diet (Naggert1_pctfat_fat8), total cholesterol after 17 weeks on atherogenic diet (Paigen2_CHOL_fat17), fold change in total cholesterol after 17 weeks on atherogenic diet (Paigen2_CHOL_chg), and non-HDL cholesterol after 17 wks on atherogenic diet (Paigen2_nonHDL_fat17). Gpr39 has knockout phenotypes on both obesity and blood cholesterol levels.</p></caption><graphic xlink:href="pone.0000651.g006"/></fig></sec></sec><sec id="s3"><title>Discussion</title><p>We have demonstrated the robustness and reproducibility of GWA analysis by comparing QTLs derived from GWA with those derived from previous linkage analyses in inbred mice. In a recent GWA analysis of lung tumor incidence, we reproduced the pulmonary adenoma susceptibility 1 (Pas1) locus identified in previous linkage studies and further narrowed this QTL to a region of less than 0.5 Mb in which at least two genes, Kras2 and Casc1, are strong candidates <xref ref-type="bibr" rid="pone.0000651-Liu1">&#x0005b;4&#x0005d;</xref>. The refined region is completely coincident with that from traditional fine mapping by using congenic strains of mice <xref ref-type="bibr" rid="pone.0000651-Zhang2">&#x0005b;32&#x0005d;</xref>. Casc1 knockout mouse tumor bioassays further confirmed Casc1 as a primary candidate for the <italic>Pas1</italic> locus <xref ref-type="bibr" rid="pone.0000651-Liu1">&#x0005b;4&#x0005d;</xref>. In the present study, we again reproduced and narrowed the Bwtq1 locus to a region of less than 1.0 Mb where Pappa2 is a primary candidate. The refined Bwtq1 region is identical to that achieved by developing a series of congenic mice and interval-specific subcongenic mice <xref ref-type="bibr" rid="pone.0000651-Christians2">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000651-Christians3">&#x0005b;14&#x0005d;</xref>. These results demonstrate that GWA scans using dense SNP maps in laboratory mice are a powerful tool for the refinement of previously identified QTL regions. These results can be also served as an internal control for the methods that we used in our GWA scans. Given that known refined QTLs were exactly reproduced in the analyses, the newly refined QTLs identified by our GWA scans are expected to be a useful resource for further positional cloning and gene discovery in the mouse. It should be also noted that 937 QTLs identified in our study represent about one half of all QTLs derived from linkage analyses in mouse cross-breeding experiments in the past decades (<ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org">http://www.informatics.jax.org</ext-link>).</p><p>Research tools such as genetrap mutations, transgenes, and standard knockout technology can be used to verify causal variants from highly-refined QTL regions immediately after GWA scans <xref ref-type="bibr" rid="pone.0000651-Flaherty1">&#x0005b;33&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000651-Nadeau1">&#x0005b;34&#x0005d;</xref>. Using resources from murine gene-deficiency and/or transgenic models, we have identified 10 candidate genes affecting obesity-related phenotypes and 11 candidate genes affecting plasma cholesterol levels from a survey of several highly refined QTLs (<xref ref-type="table" rid="pone-0000651-t002"><bold>Table 2</bold></xref> and <xref ref-type="table" rid="pone-0000651-t003"><bold>3</bold></xref>). These QTL genes are most likely the causal genes based on the following evidence. First, the genomic regions where these genes are located are not only highly associated with the analyzed phenotypes in the GWA scans, but are also under the linkage peak from two or more independent linkage studies with crossing-breeding experiments <xref ref-type="bibr" rid="pone.0000651-Rankinen1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000651-Rollins1">&#x0005b;22&#x0005d;</xref>. Second, these candidates were identified from a highly refined genomic region, as narrow as 0.54 Mb (with an average of 6 genes per region), which is extremely more precise than those chosen from a much broader linkage region (about 20 Mb). Third, and more importantly, relevant phenotypes for these genes were observed in murine knockout and/or transgenic models. Notably, due to the single-gene resolution achieved by our GWA scans, we firmly establish two QTL genes, Adam12 and Cdh2, as causal variants for obesity in inbred mice. It is also worth noting that in the present study we only focused on 28 obesity and cholesterol QTLs out of 937 QTLs, which have available data from murine knockout and/or transgenic models (<xref ref-type="table" rid="pone-0000651-t002"><bold>Table 2</bold></xref> and <xref ref-type="table" rid="pone-0000651-t003"><bold>3</bold></xref>). Other QTL genes identified in this study are now ready to be evaluated for their functional relevance to the analyzed mouse phenotypes. We have summarized this extremely valuable QTL resource in online <xref ref-type="supplementary-material" rid="pone.0000651.s002"><bold>Table S1</bold></xref> and <xref ref-type="supplementary-material" rid="pone.0000651.s003"><bold>S2</bold></xref>; this resource can greatly facilitate positional cloning and the identification of new genetic determinants of complex traits.</p><p>Finally, several caveats for our findings should be mentioned. Firstly, selection and inbreeding play important roles in the formation of the genetic architecture of mouse inbred strains. Potential population structure may arise in these mouse strains, which inflates type I error rates and may lead to spurious associatons in the analysis <xref ref-type="bibr" rid="pone.0000651-Wade1">&#x0005b;3&#x0005d;</xref>. Wild-derived inbred mice have divergent evolutionary histories and thus have strong potential to generate spurious assocations. There are systematic differences in obesity-related trait values between wild-derived and other inbred strains. Therefore, the population structure was carefully inspected in our association analysis, and we removed wild-derived inbred strains from the analysis when population structure was detected. Spurious associations were largely reduced in the analysis after the removal of wild-derived inbred mouse strains (<xref ref-type="supplementary-material" rid="pone.0000651.s010"><bold>Figure S7</bold></xref> and <xref ref-type="supplementary-material" rid="pone.0000651.s001"><bold>Text S1</bold></xref>). Several methods have been developed that adjust for the effect of population structure on spurious assocations <xref ref-type="bibr" rid="pone.0000651-Zhao1">&#x0005b;35&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000651-Devlin1">&#x0005b;38&#x0005d;</xref>, but these may not be sufficient for the analysis of a small number of mouse inbred strains (&#x0223c;30&#x02013;40 strains) <xref ref-type="bibr" rid="pone.0000651-Marchini1">&#x0005b;39&#x0005d;</xref>. Secondly, we used permutations to establish stringent genome-wide thresholds for declaring significant association for each phenotype. Although most genomic regions show correct type I error rates, some regions may show increased error rates due to unequal relatedness among the strains <xref ref-type="bibr" rid="pone.0000651-Payseur1">&#x0005b;40&#x0005d;</xref>. The risk of these spurious associations can be alleviated when incorporating prior linkage evidence into the analysis. The identified QTL genes located within previous linkages that have been replicated in two or more independent studies should be prioritized for further investigation. The associated QTL alleles need to be checked to see if they are segregated in linkage mapping populations. We have demonstrated this strategy in a recent study in which the positional cloning of a novel QTL gene, from a previous linkage-defined region, was done immediately after a GWA analysis <xref ref-type="bibr" rid="pone.0000651-Liu1">&#x0005b;4&#x0005d;</xref>. Thirdly, we estimated power of association analysis using classical inbred mouse strains through simulation studies (<xref ref-type="supplementary-material" rid="pone.0000651.s011"><bold>Figure S8</bold></xref> and <xref ref-type="supplementary-material" rid="pone.0000651.s001"><bold>Text S1</bold></xref>). GWA scans have reasonable power to detect QTL genes with major effects, while are limited to detect QTL genes with moderate effects. However, focusing association analysis on linkage-defined regions can dramatically increase statistical power and has sufficient power to detect moderate-effect QTL genes. In our results, the great majority of the QTLs identified in the GWA scans overlapped with previous linkage-defined regions from mouse crosses which were retrieved from the Mouse Genome Informatics (MGI) at <ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org">http://www.informatics.jax.org</ext-link>. Nevertheless, association results for small-effect QTLs from non-linkage regions should be interpreted with caution. It should also be noted that statistical power of association analysis in inbred mice can be significantly improved by increasing the number of mice per strain used in phenotype measurement. Fourthly, most SNPs were discovered by comparison of the genomes of several classical inbred laboratory mouse strains (such as C57BL/6J, DBA/2J, A/J and 129S1/SvImJ). Very few SNPs show polymorphisms among wild-derived strains. The ascertainment bias of SNPs will affect population inference including linkage disequilibrium and population structure. This ascertainment bias will also likely erode the power of tests of association between genotype and phenotype. However it is unlikely that the ascertainment bias will introduce false-positive inferences <xref ref-type="bibr" rid="pone.0000651-Clark1">&#x0005b;41&#x0005d;</xref>.</p></sec><sec sec-type="methods" id="s4"><title>Methods</title><sec id="s4a"><title>Mouse phenotypes and SNP data</title><p>Mouse phenotypes were generated by the mouse PHENOME projects (<ext-link ext-link-type="uri" xlink:href="http://phenome.jax.org/pub-cgi/phenome/mpdcgi&#x0003f;">http://phenome.jax.org/pub-cgi/phenome/mpdcgi?</ext-link>rtn&#x0200a;&#x0003d;&#x0200a;docs/home). In most PHENOME projects, each phenotype was measured for about 40 strains from a total of 59 inbred strains of mice. The strains used for phenotyping varied slightly among different projects. Generally, at least 10 males and 10 females from each strain were measured for each phenotype when 10&#x02013;14 weeks of age. Before statistical analysis was conducted, the phenotypic data were subjected to detection of outliers using box plot (<ext-link ext-link-type="uri" xlink:href="http://www.itl.nist.gov/div898/handbook/">http://www.itl.nist.gov/div898/handbook/</ext-link>) (<xref ref-type="supplementary-material" rid="pone.0000651.s001"><bold>Text S1</bold></xref>). The SNP data were obtained from the Wellcome Trust Centre for Human Genetics (WTCHG) at Oxford University (<ext-link ext-link-type="uri" xlink:href="http://www.well.ox.ac.uk/mouse/INBREDS">http://www.well.ox.ac.uk/mouse/INBREDS</ext-link>) and the Broad Institute of Harvard and MIT (<ext-link ext-link-type="uri" xlink:href="http://www.broad.mit.edu/personal/claire/MouseHapMap/Inbred.htm">http://www.broad.mit.edu/personal/claire/MouseHapMap/Inbred.htm</ext-link>). The genomic positions (in bp) of the SNPs for the two data sets were unified based on the latest NCBI mouse genome map build 36.1. These SNPs were further selected by removing SNPs with fewer than 20 strains typed or without genetic mapping information. The resulting SNP data include 148,062 SNPs spanning the mouse genome at an average density of &#x0223c;18 kb per SNP. The SNP genotyping accuracy reported by the WTCHG and the Broad Institute is over 99.8&#x00025;. It is worth noting that several strains used in the analysis only have available WTCHG SNP data. Thirty-seven additional SNPs chosen from Perlegen Sciences were genotyped to fill gaps in QTL regions covering Adam12 and Cdh2.</p></sec><sec id="s4b"><title>Whole-genome LD patterns</title><p>The commonly used pairwise LD measure, <italic>r<sup>2</sup></italic>, which is the squared correlation coefficient of alleles at two loci <xref ref-type="bibr" rid="pone.0000651-Hedrick1">&#x0005b;42&#x0005d;</xref>, was calculated for pairwise SNPs on the mouse genome. To capture large-scale patterns of LD, we measured the number of proxies, i.e. SNPs showing a strong correlation with one or more others <xref ref-type="bibr" rid="pone.0000651-Altshuler1">&#x0005b;9&#x0005d;</xref>, with a window size of 500 kb across the genome.</p></sec><sec id="s4c"><title>GWA scans</title><p>A full description of statistical methods for GWA scans is provided in <xref ref-type="supplementary-material" rid="pone.0000651.s001"><bold>Text S1</bold></xref>. Briefly, the associations of a mouse phenotype with SNP markers on the genome were tested by using linear regression models. To maximize power in GWA scans, we examined several competitive models with different variables based on Bayesian information criteria. The log-likelihood-ratio test statistic for the existence of a QTL is calculated by comparing the likelihood values under full model with null model. In the results, the negative 10-base logarithmic p value from <italic>x</italic><sup>2</sup> tests, i.e. &#x02013;log(P), was presented. Population structure was investigated by the cumulative distribution of p values in genome-wide association analysis for each phenotype <xref ref-type="bibr" rid="pone.0000651-Zhao1">&#x0005b;35&#x0005d;</xref>. We removed wild-derived inbred strains in the association analysis when population structure was detected.</p><p>In the GWA scans, 1,000 permutations were used to establish a genome-wide threshold (a global p value of 0.05) for declaring significant associations for each phenotype. Specifically, the analyzed phenotype was randomly reshuffled among subjects while fixing the genotypes. For each of the 1,000 permutations, the GWA scan was repeated, and the most significant &#x02013;log(P) was recorded. Sorting the maximum &#x02013;log(P) from large to small, the 5&#x00025; quantile of the empirical distribution was taken as the genome-wide threshold (a global p value of 0.05). Since LD extends a very short genomic region (normally less than a few hundred kb) on the mouse genome, once a significant SNP is identified, a causal variant responsible for the QTL should be close to the identified SNP. To define approximate QTL regions, we first identified significant SNPs with an established empirical threshold. If two significant SNPs were less than 1,000 kb from each other, they were treated as one association signal. Then these genomic regions were extended to cover closely linked SNPs that showed suggestive associations with the analyzed traits. We also reported p values, physical positions and genomic domains for each significant SNP. The identified QTLs were compared with those detected by previous linkage analyses from mouse crosses which were retrieved from Mouse Genome Informatics (MGI) at <ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org">http://www.informatics.jax.org</ext-link>.</p></sec><sec id="s4d"><title>Data transformation</title><p>To avoid the violation of assumption of normal distribution in the above statistical analysis, 173 quantitative phenotypes were checked for their normality by Shapiro-Wilk tests <xref ref-type="bibr" rid="pone.0000651-Royston1">&#x0005b;43&#x0005d;</xref> before GWA scans. Phenotypes with Shapiro-Wilk tests P&#x0003c;0.05 were converted to approach normality by Box-Cox transformation or normal scores <xref ref-type="bibr" rid="pone.0000651-Altman1">&#x0005b;44&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000651-Box1">&#x0005b;45&#x0005d;</xref>. For those phenotypes still showing marked departure from the normal distribution (p&#x0003c;0.01) after data transformation, the Mann-Whitney rank tests were performed in the GWA scans <xref ref-type="bibr" rid="pone.0000651-Hollander1">&#x0005b;46&#x0005d;</xref>.</p></sec><sec id="s4e"><title>Heritability</title><p>The heritability of inbred strains can be estimated by linear regression models with sex, strain and sex-strain interaction as independent variables. Each strain was treated as a categorical variable in the linear model analyses. The difference between the adjusted <italic>R<sup>2</sup></italic> of the regression models with and without strain and its associated sex-strain interaction is approximately equal to the percentage of genetic variation (that is, heritability) in inbred mouse populations. Similarly, the phenotypic variation due to sex differences can also be estimated.</p></sec><sec id="s4f"><title>Phylogenetic analysis</title><p>The phylogenetic tree was constructed with 148,062 SNPs from 59 inbred mouse strains, implemented in the <italic>dnadist</italic> program in the PHYLIP 3.66 package (<ext-link ext-link-type="uri" xlink:href="http://evolution.genetics.washington.edu/phylip.html">http://evolution.genetics.washington.edu/phylip.html</ext-link>). Branch length information was used to plot evolutionary distance between strains in the <italic>drawtree</italic> program in the PHYLIP 3.66 package.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0000651.s001"><label>Text S1</label><caption><p>Supporting methods: A detailed description of methods and materials.</p><p>(0.11 MB DOC)</p></caption><media xlink:href="pone.0000651.s001.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0000651.s002"><label>Table S1</label><caption><p>173 mouse quantitative traits analyzed in genome-wide association analyses. The table gives empirical genome-wide threshold, the number of QTLs and significant SNPs detected in GWA scans for each trait. The table also lists project names, mouse phenome database (MPD) accession numbers, short and full name of traits, and categories of traits.</p><p>(0.36 MB DOC)</p></caption><media xlink:href="pone.0000651.s002.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0000651.s003"><label>Table S2</label><caption><p>Summary of 937 QTL identified in genome-wide association analyses. The table gives the chromosome, position of QTL peak (bp, based on the NCBI genome build 36), QTL interval, and -log (P) for each QTL identified in GWA scans. The table also provides the SNP ID of the most significant SNP and its dbSNP's annotation if available, and total number of significant and suggestive SNPs for each QTL.</p><p>(1.99 MB DOC)</p></caption><media xlink:href="pone.0000651.s003.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0000651.s004"><label>Figure S1</label><caption><p>Distribution of SNP positions and LD structure across the mouse genome. For each chromosome, the top panel shows number of SNPs in a window size of 500 kb. The bottom panel shows number of proxies (red lines for r&#x002c6;2&#x0003e;0.5 and blue lines for r&#x002c6;2&#x0003e;0.8) per SNP in a window size of 500 kb.</p><p>(0.41 MB PDF)</p></caption><media xlink:href="pone.0000651.s004.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0000651.s005"><label>Figure S2</label><caption><p>Characteristics of the mouse SNP map. (A) Distribution of SNP allele frequency. (B) Distribution of inter-SNP distances. (C) LD decay as a function of physical distance. (D) Number of proxies per SNP in a window size of 500 kb, as a function of the threshold for correlation (r&#x002c6;2).</p><p>(0.90 MB PDF)</p></caption><media xlink:href="pone.0000651.s005.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0000651.s006"><label>Figure S3</label><caption><p>Phylogenetic tree of 59 inbred mouse strains. The phylogenetic tree was constructed with a total of 148,062 SNPs from the WTCHG and Broad Institute, implemented in the dnadist program in the PHYLIP 3.66 package (<ext-link ext-link-type="uri" xlink:href="http://evolution.genetics.washington.edu/phylip.html">http://evolution.genetics.washington.edu/phylip.html</ext-link>). The branch length information was used to plot evolutionary distance between strains in the drawtree program. 59 inbred mouse strains are organized into seven groups: Bagg albino derivatives, C57-related strains, Castle's mice, Japanese and New Zealand inbred strains, Little's DBA and related strains, Swiss mice, and wild-derived strains.</p><p>(1.41 MB PDF)</p></caption><media xlink:href="pone.0000651.s006.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0000651.s007"><label>Figure S4</label><caption><p>Characteristics of 173 complex quantitative traits in inbred mice. (A) Heritability of quantitative traits. (B) Phenotypic variation due to sex effects.</p><p>(0.70 MB PDF)</p></caption><media xlink:href="pone.0000651.s007.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0000651.s008"><label>Figure S5</label><caption><p>An in silico strategy for high-throughput gene discovery in inbred mice. GWA scans were implemented in an automatic processing pipeline which constitutes data retrieving, outlier detection, data preprocessing, hypothesis testing, permutations and QTL identification.</p><p>(0.21 MB PDF)</p></caption><media xlink:href="pone.0000651.s008.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0000651.s009"><label>Figure S6</label><caption><p>Genome-wide association analysis of several obesity-related phenotypes in inbred mice. The obesity-relaed phenotypes are (A) body weight at the start of testing (8 weeks) (Tordoff3_bw_start); (B) calculated weight of lean tissue (14 weeks) (Tordoff3_lean_wt); (C) body weight after 8 weeks on an atherogenic diet (Naggert1_bw_fat8); (D) total tissue mass after 8 weeks on an atherogenic diet (Naggert1_tissuemass_fat8); (E) weight of lean portion of tissue mass after 8 weeks on an atherogenic diet (Naggert1_leanwt_fat8); (F) bone mineral content after 8 weeks on an atherogenic diet (Naggert1_BMC_fat8); (G) initial body weight (7&#x02013;9 weeks), day 0 of an atherogenic diet (Paigen1_initbw); and (H) final body weight after 8 weeks on an atherogenic diet (Paigen1_finalbw). In Paigen1 and Naggert1 projects, mice at 7&#x02013;9 weeks of age were weighed and then administered a high fat, high cholesterol atherogenic diet. The scatter plots were drawn for -log (P) against the SNP position in the chromosomes. The horizontal gray lines indicate genome-wide empirical thresholds (global p value&#x0200a;&#x0003d;&#x0200a;0.05). The horizontal coordinates were plotted using physical distance (Mb) in each panel.</p><p>(7.96 MB PDF)</p></caption><media xlink:href="pone.0000651.s009.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0000651.s010"><label>Figure S7</label><caption><p>Potential population structure in inbred mice. Body weight after 8 weeks on altherogenic diet (Naggert1_bw_fat8) was used to illustrate the population structure in inbred mice. (A) Cummlative distribution of p values from GWA analysis of samples with (red line) and without (blue line) wild-derived inbred strains. cdf, cumulative distribution function. (B) Comparison of GWA analysis of samples with (upper, red) and without (lower, blue) wild-derived inbred strains. The two green horizontal lines are genome-wide thresholds (a global p value of 0.05). Spurious assocaitons were largely reduced in the analysis after the removal of wild-derived inbred mouse strains.</p><p>(1.78 MB PDF)</p></caption><media xlink:href="pone.0000651.s010.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0000651.s011"><label>Figure S8</label><caption><p>Power of association analysis in inbred mice. Power was estimated for different trait heritabilities under genome-wide and QTL-wide thresholds (P&#x0200a;&#x0003d;&#x0200a;0.05). The genome-wide threshold is used to declare a significant association on the genome without any prior genetic evidence; while the QTL-wide threshold is used to declare a significant association on a privious linkage-defined region.</p><p>(0.48 MB PDF)</p></caption><media xlink:href="pone.0000651.s011.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank the Jackson Laboratory and investigators (a detailed list of investigators of the mouse PHENOME projects is provided in the <xref ref-type="supplementary-material" rid="pone.0000651.s001"><bold>Text S1</bold></xref>) for collecting and phenotyping inbred mouse strain characteristics. We thank the Broad Institute of Harvard/Massachusetts General Hospital and MIT, the Wellcome Trust Center for Human Genetics at Oxford University, and Perlegen Sciences for releasing inbred laboratory mouse SNP data. The mouse phenotype and SNP data were crucial for the key findings described in this paper.</p></ack><ref-list><title>References</title><ref id="pone.0000651-Waterston1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waterston</surname><given-names>RH</given-names></name><name><surname>Lindblad-Toh</surname><given-names>K</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name><name><surname>Rogers</surname><given-names>J</given-names></name><name><surname>Abril</surname><given-names>JF</given-names></name><etal/></person-group><year>2002</year><article-title>Initial sequencing and comparative analysis of the mouse genome.</article-title><source>Nature</source><volume>420</volume><fpage>520</fpage><lpage>562</lpage><pub-id pub-id-type="pmid">12466850</pub-id></citation></ref><ref id="pone.0000651-Peters1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>LL</given-names></name><name><surname>Robledo</surname><given-names>RF</given-names></name><name><surname>Bult</surname><given-names>CJ</given-names></name><name><surname>Churchill</surname><given-names>GA</given-names></name><name><surname>Paigen</surname><given-names>BJ</given-names></name><etal/></person-group><year>2007</year><article-title>The mouse as a model for human biology: a resource guide for complex trait analysis.</article-title><source>Nat Rev Genet</source><volume>8</volume><fpage>58</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">17173058</pub-id></citation></ref><ref id="pone.0000651-Wade1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wade</surname><given-names>CM</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name></person-group><year>2005</year><article-title>Genetic variation in laboratory mice.</article-title><source>Nat Genet</source><volume>37</volume><fpage>1175</fpage><lpage>1180</lpage><pub-id pub-id-type="pmid">16254563</pub-id></citation></ref><ref id="pone.0000651-Liu1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Vikis</surname><given-names>H</given-names></name><name><surname>Maciag</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><etal/></person-group><year>2006</year><article-title>Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice.</article-title><source>Nat Genet</source><volume>38</volume><fpage>888</fpage><lpage>895</lpage><pub-id pub-id-type="pmid">16862160</pub-id></citation></ref><ref id="pone.0000651-Liao1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Allard</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><etal/></person-group><year>2004</year><article-title>In silico genetics: identification of a functional element regulating H2-Ealpha gene expression.</article-title><source>Science</source><volume>306</volume><fpage>690</fpage><lpage>695</lpage><pub-id pub-id-type="pmid">15499019</pub-id></citation></ref><ref id="pone.0000651-Grupe1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grupe</surname><given-names>A</given-names></name><name><surname>Germer</surname><given-names>S</given-names></name><name><surname>Usuka</surname><given-names>J</given-names></name><name><surname>Aud</surname><given-names>D</given-names></name><name><surname>Belknap</surname><given-names>JK</given-names></name><etal/></person-group><year>2001</year><article-title>In silico mapping of complex disease-related traits in mice.</article-title><source>Science</source><volume>292</volume><fpage>1915</fpage><lpage>1918</lpage><pub-id pub-id-type="pmid">11397946</pub-id></citation></ref><ref id="pone.0000651-Pletcher1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pletcher</surname><given-names>MT</given-names></name><name><surname>McClurg</surname><given-names>P</given-names></name><name><surname>Batalov</surname><given-names>S</given-names></name><name><surname>Su</surname><given-names>AI</given-names></name><name><surname>Barnes</surname><given-names>SW</given-names></name><etal/></person-group><year>2004</year><article-title>Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse.</article-title><source>PLoS Biol</source><volume>2</volume><fpage>e393</fpage><pub-id pub-id-type="pmid">15534693</pub-id></citation></ref><ref id="pone.0000651-Valdar1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Valdar</surname><given-names>W</given-names></name><name><surname>Solberg</surname><given-names>LC</given-names></name><name><surname>Gauguier</surname><given-names>D</given-names></name><name><surname>Burnett</surname><given-names>S</given-names></name><name><surname>Klenerman</surname><given-names>P</given-names></name><etal/></person-group><year>2006</year><article-title>Genome-wide genetic association of complex traits in heterogeneous stock mice.</article-title><source>Nat Genet</source><volume>38</volume><fpage>879</fpage><lpage>887</lpage><pub-id pub-id-type="pmid">16832355</pub-id></citation></ref><ref id="pone.0000651-Altshuler1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Altshuler</surname><given-names>D</given-names></name><name><surname>Brooks</surname><given-names>LD</given-names></name><name><surname>Chakravarti</surname><given-names>A</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Daly</surname><given-names>MJ</given-names></name><etal/></person-group><year>2005</year><article-title>A haplotype map of the human genome.</article-title><source>Nature</source><volume>437</volume><fpage>1299</fpage><lpage>1320</lpage><pub-id pub-id-type="pmid">16255080</pub-id></citation></ref><ref id="pone.0000651-Rankinen1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rankinen</surname><given-names>T</given-names></name><name><surname>Zuberi</surname><given-names>A</given-names></name><name><surname>Chagnon</surname><given-names>YC</given-names></name><name><surname>Weisnagel</surname><given-names>SJ</given-names></name><name><surname>Argyropoulos</surname><given-names>G</given-names></name><etal/></person-group><year>2006</year><article-title>The human obesity gene map: the 2005 update.</article-title><source>Obesity (Silver Spring)</source><volume>14</volume><fpage>529</fpage><lpage>644</lpage><pub-id pub-id-type="pmid">16741264</pub-id></citation></ref><ref id="pone.0000651-Morris1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>KH</given-names></name><name><surname>Ishikawa</surname><given-names>A</given-names></name><name><surname>Keightley</surname><given-names>PD</given-names></name></person-group><year>1999</year><article-title>Quantitative trait loci for growth traits in C57BL/6J&#x000d7;DBA/2J mice.</article-title><source>Mamm Genome</source><volume>10</volume><fpage>225</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">10051315</pub-id></citation></ref><ref id="pone.0000651-Christians1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christians</surname><given-names>JK</given-names></name><name><surname>Bingham</surname><given-names>VK</given-names></name><name><surname>Oliver</surname><given-names>FK</given-names></name><name><surname>Heath</surname><given-names>TT</given-names></name><name><surname>Keightley</surname><given-names>PD</given-names></name></person-group><year>2003</year><article-title>Characterization of a QTL affecting skeletal size in mice.</article-title><source>Mamm Genome</source><volume>14</volume><fpage>175</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">12647240</pub-id></citation></ref><ref id="pone.0000651-Christians2"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christians</surname><given-names>JK</given-names></name><name><surname>Keightley</surname><given-names>PD</given-names></name></person-group><year>2004</year><article-title>Fine mapping of a murine growth locus to a 1.4-cM region and resolution of linked QTL.</article-title><source>Mamm Genome</source><volume>15</volume><fpage>482</fpage><lpage>491</lpage><pub-id pub-id-type="pmid">15181540</pub-id></citation></ref><ref id="pone.0000651-Christians3"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christians</surname><given-names>JK</given-names></name><name><surname>Hoeflich</surname><given-names>A</given-names></name><name><surname>Keightley</surname><given-names>PD</given-names></name></person-group><year>2006</year><article-title>PAPPA2, an enzyme that cleaves an insulin-like growth-factor-binding protein, is a candidate gene for a quantitative trait locus affecting body size in mice.</article-title><source>Genetics</source><volume>173</volume><fpage>1547</fpage><lpage>1553</lpage><pub-id pub-id-type="pmid">16702428</pub-id></citation></ref><ref id="pone.0000651-Brockmann1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brockmann</surname><given-names>GA</given-names></name><name><surname>Haley</surname><given-names>CS</given-names></name><name><surname>Renne</surname><given-names>U</given-names></name><name><surname>Knott</surname><given-names>SA</given-names></name><name><surname>Schwerin</surname><given-names>M</given-names></name></person-group><year>1998</year><article-title>Quantitative trait loci affecting body weight and fatness from a mouse line selected for extreme high growth.</article-title><source>Genetics</source><volume>150</volume><fpage>369</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">9725853</pub-id></citation></ref><ref id="pone.0000651-Brockmann2"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brockmann</surname><given-names>GA</given-names></name><name><surname>Kratzsch</surname><given-names>J</given-names></name><name><surname>Haley</surname><given-names>CS</given-names></name><name><surname>Renne</surname><given-names>U</given-names></name><name><surname>Schwerin</surname><given-names>M</given-names></name><etal/></person-group><year>2000</year><article-title>Single QTL effects, epistasis, and pleiotropy account for two-thirds of the phenotypic F(2) variance of growth and obesity in DU6i&#x000d7;DBA/2 mice.</article-title><source>Genome Res</source><volume>10</volume><fpage>1941</fpage><lpage>1957</lpage><pub-id pub-id-type="pmid">11116089</pub-id></citation></ref><ref id="pone.0000651-Cheverud1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheverud</surname><given-names>JM</given-names></name><name><surname>Vaughn</surname><given-names>TT</given-names></name><name><surname>Pletscher</surname><given-names>LS</given-names></name><name><surname>Peripato</surname><given-names>AC</given-names></name><name><surname>Adams</surname><given-names>ES</given-names></name><etal/></person-group><year>2001</year><article-title>Genetic architecture of adiposity in the cross of LG/J and SM/J inbred mice.</article-title><source>Mamm Genome</source><volume>12</volume><fpage>3</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">11178736</pub-id></citation></ref><ref id="pone.0000651-Vaughn1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaughn</surname><given-names>TT</given-names></name><name><surname>Pletscher</surname><given-names>LS</given-names></name><name><surname>Peripato</surname><given-names>A</given-names></name><name><surname>King-Ellison</surname><given-names>K</given-names></name><name><surname>Adams</surname><given-names>E</given-names></name><etal/></person-group><year>1999</year><article-title>Mapping quantitative trait loci for murine growth: a closer look at genetic architecture.</article-title><source>Genet Res</source><volume>74</volume><fpage>313</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">10689807</pub-id></citation></ref><ref id="pone.0000651-Bymaster1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bymaster</surname><given-names>FP</given-names></name><name><surname>McKinzie</surname><given-names>DL</given-names></name><name><surname>Felder</surname><given-names>CC</given-names></name><name><surname>Wess</surname><given-names>J</given-names></name></person-group><year>2003</year><article-title>Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system.</article-title><source>Neurochem Res</source><volume>28</volume><fpage>437</fpage><lpage>442</lpage><pub-id pub-id-type="pmid">12675128</pub-id></citation></ref><ref id="pone.0000651-Yamada1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>M</given-names></name><name><surname>Miyakawa</surname><given-names>T</given-names></name><name><surname>Duttaroy</surname><given-names>A</given-names></name><name><surname>Yamanaka</surname><given-names>A</given-names></name><name><surname>Moriguchi</surname><given-names>T</given-names></name><etal/></person-group><year>2001</year><article-title>Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean.</article-title><source>Nature</source><volume>410</volume><fpage>207</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">11242080</pub-id></citation></ref><ref id="pone.0000651-Brewer1"><label>21</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Brewer</surname><given-names>HBJ</given-names></name><name><surname>Santamarina-Fojo</surname><given-names>S</given-names></name><name><surname>Shamburek</surname><given-names>RD</given-names></name></person-group><year>2005</year><article-title>Genetic dyslipoproteinemias.</article-title><person-group person-group-type="editor"><name><surname>Fuster</surname><given-names>V</given-names></name><name><surname>Topol</surname><given-names>EJ</given-names></name><name><surname>Nabel</surname><given-names>EG</given-names></name></person-group><source>Atherothrombosis and coronary artery disease</source><publisher-loc>Philadelphia, PA</publisher-loc><publisher-name>Lippincott Williams&#x00026;Wilkins</publisher-name><fpage>55</fpage><lpage>83</lpage></citation></ref><ref id="pone.0000651-Rollins1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rollins</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Paigen</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name></person-group><year>2006</year><article-title>In search of new targets for plasma high-density lipoprotein cholesterol levels: promise of human-mouse comparative genomics.</article-title><source>Trends Cardiovasc Med</source><volume>16</volume><fpage>220</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">16980179</pub-id></citation></ref><ref id="pone.0000651-Weng1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>W</given-names></name><name><surname>Breslow</surname><given-names>JL</given-names></name></person-group><year>1996</year><article-title>Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility.</article-title><source>Proc Natl Acad Sci U S A</source><volume>93</volume><fpage>14788</fpage><lpage>14794</lpage><pub-id pub-id-type="pmid">8962133</pub-id></citation></ref><ref id="pone.0000651-Masaki1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Masaki</surname><given-names>M</given-names></name><name><surname>Kurisaki</surname><given-names>T</given-names></name><name><surname>Shirakawa</surname><given-names>K</given-names></name><name><surname>Sehara-Fujisawa</surname><given-names>A</given-names></name></person-group><year>2005</year><article-title>Role of meltrin {alpha} (ADAM12) in obesity induced by high- fat diet.</article-title><source>Endocrinology</source><volume>146</volume><fpage>1752</fpage><lpage>1763</lpage><pub-id pub-id-type="pmid">15637293</pub-id></citation></ref><ref id="pone.0000651-Castro1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname><given-names>CH</given-names></name><name><surname>Shin</surname><given-names>CS</given-names></name><name><surname>Stains</surname><given-names>JP</given-names></name><name><surname>Cheng</surname><given-names>SL</given-names></name><name><surname>Sheikh</surname><given-names>S</given-names></name><etal/></person-group><year>2004</year><article-title>Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis.</article-title><source>J Cell Sci</source><volume>117</volume><fpage>2853</fpage><lpage>2864</lpage><pub-id pub-id-type="pmid">15169841</pub-id></citation></ref><ref id="pone.0000651-Zhang1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>JV</given-names></name><name><surname>Ren</surname><given-names>PG</given-names></name><name><surname>Avsian-Kretchmer</surname><given-names>O</given-names></name><name><surname>Luo</surname><given-names>CW</given-names></name><name><surname>Rauch</surname><given-names>R</given-names></name><etal/></person-group><year>2005</year><article-title>Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake.</article-title><source>Science</source><volume>310</volume><fpage>996</fpage><lpage>999</lpage><pub-id pub-id-type="pmid">16284174</pub-id></citation></ref><ref id="pone.0000651-Moechars1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moechars</surname><given-names>D</given-names></name><name><surname>Depoortere</surname><given-names>I</given-names></name><name><surname>Moreaux</surname><given-names>B</given-names></name><name><surname>de Smet</surname><given-names>B</given-names></name><name><surname>Goris</surname><given-names>I</given-names></name><etal/></person-group><year>2006</year><article-title>Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor-knockout mouse.</article-title><source>Gastroenterology</source><volume>131</volume><fpage>1131</fpage><lpage>1141</lpage><pub-id pub-id-type="pmid">17030183</pub-id></citation></ref><ref id="pone.0000651-Chartrel1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chartrel</surname><given-names>N</given-names></name><name><surname>Alvear-Perez</surname><given-names>R</given-names></name><name><surname>Leprince</surname><given-names>J</given-names></name><name><surname>Iturrioz</surname><given-names>X</given-names></name><name><surname>Reaux-Le Goazigo</surname><given-names>A</given-names></name><etal/></person-group><year>2007</year><article-title>Comment on &#x0201c;Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake&#x0201d;.</article-title><source>Science</source><volume>315</volume><fpage>766; author reply 766</fpage><pub-id pub-id-type="pmid">17289961</pub-id></citation></ref><ref id="pone.0000651-Holst1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holst</surname><given-names>B</given-names></name><name><surname>Egerod</surname><given-names>KL</given-names></name><name><surname>Schild</surname><given-names>E</given-names></name><name><surname>Vickers</surname><given-names>SP</given-names></name><name><surname>Cheetham</surname><given-names>S</given-names></name><etal/></person-group><year>2007</year><article-title>GPR39 signaling is stimulated by zinc ions but not by obestatin.</article-title><source>Endocrinology</source><volume>148</volume><fpage>13</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">16959833</pub-id></citation></ref><ref id="pone.0000651-Lauwers1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lauwers</surname><given-names>E</given-names></name><name><surname>Landuyt</surname><given-names>B</given-names></name><name><surname>Arckens</surname><given-names>L</given-names></name><name><surname>Schoofs</surname><given-names>L</given-names></name><name><surname>Luyten</surname><given-names>W</given-names></name></person-group><year>2006</year><article-title>Obestatin does not activate orphan G protein-coupled receptor GPR39.</article-title><source>Biochem Biophys Res Commun</source><volume>351</volume><fpage>21</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">17054911</pub-id></citation></ref><ref id="pone.0000651-Tremblay1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tremblay</surname><given-names>F</given-names></name><name><surname>Perreault</surname><given-names>M</given-names></name><name><surname>Klaman</surname><given-names>LD</given-names></name><name><surname>Tobin</surname><given-names>JF</given-names></name><name><surname>Smith</surname><given-names>E</given-names></name><etal/></person-group><year>2007</year><article-title>Normal food intake and body weight in mice lacking the G protein-coupled receptor GPR39.</article-title><source>Endocrinology</source><volume>148</volume><fpage>501</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">17095592</pub-id></citation></ref><ref id="pone.0000651-Zhang2"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Futamura</surname><given-names>M</given-names></name><name><surname>Vikis</surname><given-names>HG</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><year>2003</year><article-title>Positional cloning of the major quantitative trait locus underlying lung tumor susceptibility in mice.</article-title><source>Proc Natl Acad Sci U S A</source><volume>100</volume><fpage>12642</fpage><lpage>12647</lpage><pub-id pub-id-type="pmid">14583591</pub-id></citation></ref><ref id="pone.0000651-Flaherty1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flaherty</surname><given-names>L</given-names></name><name><surname>Herron</surname><given-names>B</given-names></name><name><surname>Symula</surname><given-names>D</given-names></name></person-group><year>2005</year><article-title>Genomics of the future: identification of quantitative trait loci in the mouse.</article-title><source>Genome Res</source><volume>15</volume><fpage>1741</fpage><lpage>1745</lpage><pub-id pub-id-type="pmid">16339372</pub-id></citation></ref><ref id="pone.0000651-Nadeau1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nadeau</surname><given-names>JH</given-names></name><name><surname>Frankel</surname><given-names>WN</given-names></name></person-group><year>2000</year><article-title>The roads from phenotypic variation to gene discovery: mutagenesis versus QTLs.</article-title><source>Nat Genet</source><volume>25</volume><fpage>381</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">10932178</pub-id></citation></ref><ref id="pone.0000651-Zhao1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>K</given-names></name><name><surname>Aranzana</surname><given-names>MJ</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Lister</surname><given-names>C</given-names></name><name><surname>Shindo</surname><given-names>C</given-names></name><etal/></person-group><year>2007</year><article-title>An Arabidopsis Example of Association Mapping in Structured Samples.</article-title><source>PLoS Genet</source><volume>3</volume><fpage>e4</fpage><pub-id pub-id-type="pmid">17238287</pub-id></citation></ref><ref id="pone.0000651-Yu1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Pressoir</surname><given-names>G</given-names></name><name><surname>Briggs</surname><given-names>WH</given-names></name><name><surname>Vroh Bi</surname><given-names>I</given-names></name><name><surname>Yamasaki</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>A unified mixed-model method for association mapping that accounts for multiple levels of relatedness.</article-title><source>Nat Genet</source><volume>38</volume><fpage>203</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">16380716</pub-id></citation></ref><ref id="pone.0000651-Pritchard1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pritchard</surname><given-names>JK</given-names></name><name><surname>Stephens</surname><given-names>M</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name></person-group><year>2000</year><article-title>Inference of population structure using multilocus genotype data.</article-title><source>Genetics</source><volume>155</volume><fpage>945</fpage><lpage>959</lpage><pub-id pub-id-type="pmid">10835412</pub-id></citation></ref><ref id="pone.0000651-Devlin1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Devlin</surname><given-names>B</given-names></name><name><surname>Roeder</surname><given-names>K</given-names></name></person-group><year>1999</year><article-title>Genomic control for association studies.</article-title><source>Biometrics</source><volume>55</volume><fpage>997</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">11315092</pub-id></citation></ref><ref id="pone.0000651-Marchini1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marchini</surname><given-names>J</given-names></name><name><surname>Cardon</surname><given-names>LR</given-names></name><name><surname>Phillips</surname><given-names>MS</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name></person-group><year>2004</year><article-title>The effects of human population structure on large genetic association studies.</article-title><source>Nat Genet</source><volume>36</volume><fpage>512</fpage><lpage>517</lpage><pub-id pub-id-type="pmid">15052271</pub-id></citation></ref><ref id="pone.0000651-Payseur1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Payseur</surname><given-names>BA</given-names></name><name><surname>Place</surname><given-names>M</given-names></name></person-group><year>2007</year><article-title>Prospects for Association Mapping in Classical Inbred Mouse Strains.</article-title><source>Genetics</source><volume>175</volume><fpage>1999</fpage><lpage>2008</lpage><pub-id pub-id-type="pmid">17277361</pub-id></citation></ref><ref id="pone.0000651-Clark1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>AG</given-names></name><name><surname>Hubisz</surname><given-names>MJ</given-names></name><name><surname>Bustamante</surname><given-names>CD</given-names></name><name><surname>Williamson</surname><given-names>SH</given-names></name><name><surname>Nielsen</surname><given-names>R</given-names></name></person-group><year>2005</year><article-title>Ascertainment bias in studies of human genome-wide polymorphism.</article-title><source>Genome Res</source><volume>15</volume><fpage>1496</fpage><lpage>1502</lpage><pub-id pub-id-type="pmid">16251459</pub-id></citation></ref><ref id="pone.0000651-Hedrick1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hedrick</surname><given-names>PW</given-names></name></person-group><year>1987</year><article-title>Gametic disequilibrium measures: proceed with caution.</article-title><source>Genetics</source><volume>117</volume><fpage>331</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">3666445</pub-id></citation></ref><ref id="pone.0000651-Royston1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Royston</surname><given-names>P</given-names></name></person-group><year>1982</year><article-title>An Extension of Shapiro and Wilk's W Test for Normality to Large Samples.</article-title><source>Applied Statistics</source><volume>31</volume><fpage>115</fpage><lpage>124</lpage></citation></ref><ref id="pone.0000651-Altman1"><label>44</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>DG</given-names></name></person-group><year>1991</year><article-title>Practical Statistics for Medical Research: Chapman and Hall.</article-title></citation></ref><ref id="pone.0000651-Box1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Box</surname><given-names>GEP</given-names></name><name><surname>Cox</surname><given-names>DR</given-names></name></person-group><year>1964</year><article-title>An analysis of transformations.</article-title><source>Journal of Royal Statistical Society, Series B</source><volume>26</volume><fpage>211</fpage><lpage>246</lpage></citation></ref><ref id="pone.0000651-Hollander1"><label>46</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Hollander</surname><given-names>M</given-names></name><name><surname>Wolfe</surname><given-names>DA</given-names></name></person-group><year>1973</year><article-title>Nonparametric statistical inference.</article-title><publisher-loc>New York</publisher-loc><publisher-name>John Wiley and Sons</publisher-name><fpage>68</fpage><lpage>75</lpage></citation></ref><ref id="pone.0000651-Bale1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bale</surname><given-names>TL</given-names></name><name><surname>Anderson</surname><given-names>KR</given-names></name><name><surname>Roberts</surname><given-names>AJ</given-names></name><name><surname>Lee</surname><given-names>KF</given-names></name><name><surname>Nagy</surname><given-names>TR</given-names></name><etal/></person-group><year>2003</year><article-title>Corticotropin-releasing factor receptor-2-deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold.</article-title><source>Endocrinology</source><volume>144</volume><fpage>2580</fpage><lpage>2587</lpage><pub-id pub-id-type="pmid">12746321</pub-id></citation></ref><ref id="pone.0000651-Naaz1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naaz</surname><given-names>A</given-names></name><name><surname>Holsberger</surname><given-names>DR</given-names></name><name><surname>Iwamoto</surname><given-names>GA</given-names></name><name><surname>Nelson</surname><given-names>A</given-names></name><name><surname>Kiyokawa</surname><given-names>H</given-names></name><etal/></person-group><year>2004</year><article-title>Loss of cyclin-dependent kinase inhibitors produces adipocyte hyperplasia and obesity.</article-title><source>Faseb J</source><volume>18</volume><fpage>1925</fpage><lpage>1927</lpage><pub-id pub-id-type="pmid">15469964</pub-id></citation></ref><ref id="pone.0000651-FontdeMora1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Font de Mora</surname><given-names>J</given-names></name><name><surname>Esteban</surname><given-names>LM</given-names></name><name><surname>Burks</surname><given-names>DJ</given-names></name><name><surname>Nunez</surname><given-names>A</given-names></name><name><surname>Garces</surname><given-names>C</given-names></name><etal/></person-group><year>2003</year><article-title>Ras-GRF1 signaling is required for normal beta-cell development and glucose homeostasis.</article-title><source>Embo J</source><volume>22</volume><fpage>3039</fpage><lpage>3049</lpage><pub-id pub-id-type="pmid">12805218</pub-id></citation></ref><ref id="pone.0000651-Tuncman1"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tuncman</surname><given-names>G</given-names></name><name><surname>Hirosumi</surname><given-names>J</given-names></name><name><surname>Solinas</surname><given-names>G</given-names></name><name><surname>Chang</surname><given-names>L</given-names></name><name><surname>Karin</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance.</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><fpage>10741</fpage><lpage>10746</lpage><pub-id pub-id-type="pmid">16818881</pub-id></citation></ref><ref id="pone.0000651-Longo1"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Longo</surname><given-names>KA</given-names></name><name><surname>Wright</surname><given-names>WS</given-names></name><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Gerin</surname><given-names>I</given-names></name><name><surname>Chiang</surname><given-names>SH</given-names></name><etal/></person-group><year>2004</year><article-title>Wnt10b inhibits development of white and brown adipose tissues.</article-title><source>J Biol Chem</source><volume>279</volume><fpage>35503</fpage><lpage>35509</lpage><pub-id pub-id-type="pmid">15190075</pub-id></citation></ref><ref id="pone.0000651-Wu1"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>JJ</given-names></name><name><surname>Roth</surname><given-names>RJ</given-names></name><name><surname>Anderson</surname><given-names>EJ</given-names></name><name><surname>Hong</surname><given-names>EG</given-names></name><name><surname>Lee</surname><given-names>MK</given-names></name><etal/></person-group><year>2006</year><article-title>Mice lacking MAP kinase phosphatase-1 have enhanced MAP kinase activity and resistance to diet-induced obesity.</article-title><source>Cell Metab</source><volume>4</volume><fpage>61</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">16814733</pub-id></citation></ref><ref id="pone.0000651-Goudriaan1"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goudriaan</surname><given-names>JR</given-names></name><name><surname>Dahlmans</surname><given-names>VE</given-names></name><name><surname>Teusink</surname><given-names>B</given-names></name><name><surname>Ouwens</surname><given-names>DM</given-names></name><name><surname>Febbraio</surname><given-names>M</given-names></name><etal/></person-group><year>2003</year><article-title>CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice.</article-title><source>J Lipid Res</source><volume>44</volume><fpage>2270</fpage><lpage>2277</lpage><pub-id pub-id-type="pmid">12923231</pub-id></citation></ref><ref id="pone.0000651-Miyasaka1"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miyasaka</surname><given-names>K</given-names></name><name><surname>Takata</surname><given-names>Y</given-names></name><name><surname>Funakoshi</surname><given-names>A</given-names></name></person-group><year>2002</year><article-title>Association of cholecystokinin A receptor gene polymorphism with cholelithiasis and the molecular mechanisms of this polymorphism.</article-title><source>J Gastroenterol</source><volume>37</volume><issue>Suppl 14</issue><fpage>102</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">12572876</pub-id></citation></ref><ref id="pone.0000651-Patel1"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>HR</given-names></name><name><surname>Qi</surname><given-names>Y</given-names></name><name><surname>Hawkins</surname><given-names>EJ</given-names></name><name><surname>Hileman</surname><given-names>SM</given-names></name><name><surname>Elmquist</surname><given-names>JK</given-names></name><etal/></person-group><year>2006</year><article-title>Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice.</article-title><source>Diabetes</source><volume>55</volume><fpage>3091</fpage><lpage>3098</lpage><pub-id pub-id-type="pmid">17065347</pub-id></citation></ref><ref id="pone.0000651-Akiyama1"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akiyama</surname><given-names>TE</given-names></name><name><surname>Sakai</surname><given-names>S</given-names></name><name><surname>Lambert</surname><given-names>G</given-names></name><name><surname>Nicol</surname><given-names>CJ</given-names></name><name><surname>Matsusue</surname><given-names>K</given-names></name><etal/></person-group><year>2002</year><article-title>Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.</article-title><source>Mol Cell Biol</source><volume>22</volume><fpage>2607</fpage><lpage>2619</lpage><pub-id pub-id-type="pmid">11909955</pub-id></citation></ref><ref id="pone.0000651-Weisberg1"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weisberg</surname><given-names>SP</given-names></name><name><surname>Hunter</surname><given-names>D</given-names></name><name><surname>Huber</surname><given-names>R</given-names></name><name><surname>Lemieux</surname><given-names>J</given-names></name><name><surname>Slaymaker</surname><given-names>S</given-names></name><etal/></person-group><year>2006</year><article-title>CCR2 modulates inflammatory and metabolic effects of high-fat feeding.</article-title><source>J Clin Invest</source><volume>116</volume><fpage>115</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">16341265</pub-id></citation></ref><ref id="pone.0000651-Mao1"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>J</given-names></name><name><surname>DeMayo</surname><given-names>FJ</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Abu-Elheiga</surname><given-names>L</given-names></name><name><surname>Gu</surname><given-names>Z</given-names></name><etal/></person-group><year>2006</year><article-title>Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis.</article-title><source>Proc Natl Acad Sci U S A</source><volume>103</volume><fpage>8552</fpage><lpage>8557</lpage><pub-id pub-id-type="pmid">16717184</pub-id></citation></ref><ref id="pone.0000651-Huang1"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>LS</given-names></name><name><surname>Voyiaziakis</surname><given-names>E</given-names></name><name><surname>Markenson</surname><given-names>DF</given-names></name><name><surname>Sokol</surname><given-names>KA</given-names></name><name><surname>Hayek</surname><given-names>T</given-names></name><etal/></person-group><year>1995</year><article-title>apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes.</article-title><source>J Clin Invest</source><volume>96</volume><fpage>2152</fpage><lpage>2161</lpage><pub-id pub-id-type="pmid">7593600</pub-id></citation></ref><ref id="pone.0000651-Buhman1"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buhman</surname><given-names>KK</given-names></name><name><surname>Accad</surname><given-names>M</given-names></name><name><surname>Novak</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>RS</given-names></name><name><surname>Wong</surname><given-names>JS</given-names></name><etal/></person-group><year>2000</year><article-title>Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice.</article-title><source>Nat Med</source><volume>6</volume><fpage>1341</fpage><lpage>1347</lpage><pub-id pub-id-type="pmid">11100118</pub-id></citation></ref><ref id="pone.0000651-Ishida1"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishida</surname><given-names>T</given-names></name><name><surname>Choi</surname><given-names>S</given-names></name><name><surname>Kundu</surname><given-names>RK</given-names></name><name><surname>Hirata</surname><given-names>K</given-names></name><name><surname>Rubin</surname><given-names>EM</given-names></name><etal/></person-group><year>2003</year><article-title>Endothelial lipase is a major determinant of HDL level.</article-title><source>J Clin Invest</source><volume>111</volume><fpage>347</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">12569160</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>Our research was supported by grants from the US National Institutes of Health (CA099187, CA099147, ES012063 and ES013340).</p></fn></fn-group></back></article> 